Publikationen von Luis A. Pardo

Hartung, F.; Stühmer, W.; Pardo, L. A.: Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody. Molecular Cancer 10, 109 (2011)

Chen, Y.; Sánchez, A.; Rubio, M. E.; Kohl, T.; Pardo, L. A.; Stühmer, W.: Functional KV10.1 channels localize to the inner nuclear membrane. PLoS ONE 6 (5), e19257 (2011)

Grube, S.; Gerchen, M. F.; Adamcio, B.; Pardo, L. A.; Martin, S.; Malzahn, D.; Papiol, S.; Begemann, M.; Ribbe, K.; Friedrichs, H. et al.; Radyushkin, K. A.; Müller, M.; Benseler, F.; Riggert, J.; Falkai, P.; Bickeböller, H.; Nave, K.-A.; Brose, N.; Stühmer, W.; Ehrenreich, H.: A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. Embo Molecular Medicine 3 (6), S. 309 - 319 (2011)

Agarwal, J. R.; Griesinger, F.; Stühmer, W.; Pardo, L. A.: The potassium channel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Molecular Cancer 9, 18 (2010)

Gomez-Varela, D.; Kohl, T.; Schmidt, M.; Rubio, M. E.; Kawabe, H.; Nehring, R. B.; Schäfer, S.; Stühmer, W.; Pardo, L. A.: Characterization of Eag1 channel lateral mobility in rat hippocampal cultures by single-particle-tracking with quantum dots. PLoS ONE 5 (1), e8858 (2010)

Martin, S.; Lino-de-Oliveira, C.; Joca, S. R. L.; Weffort de Oliveira, R.; Bermúdez Echeverry, M.; da Silva, C. A.; Pardo, L.; Stühmer, W.; Del Bel, E.: EAG1, EAG2 and KCNN3 gene brain expression of isolated reared rats. Genes, Brain and Behavior 9 (2), S. 918 - 924 (2010)

Stühmer, W.; Pardo, L. A.: K+ channels as therapeutic targets in oncology. Future Medicinal Chemistry 2 (5), S. 745 - 755 (2010)

Wulff, H.; Castle, N. A.; Pardo, L. A.: Voltage-gated potassium channels as therapeutic targets. Nature Reviews Drug Discovery 8, S. 982 - 1001 (2009)

Alves, F.; Dullin, C.; Napp, J.; Missbach-Guentner, J.; Jannasch, K.; Mathejczyk, J.; Pardo, L. A.; Stühmer, W.; Tietze, L.-F.: Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice. European Journal of Radiology 70 (2), S. 286 - 293 (2009)

Lörinczi, E.; Napp, J.; Contreras-Jurado, C.; Pardo, L. A.; Stühmer, W.: The voltage dependence of hEag currents is not determined solely by membrane-spanning domains. European Biophysics Journal 38 (3), S. 279 - 284 (2009)

Downie, B. R.; Sánchez, A.; Knötgen, H.; Contreras-Jurado, C.; Gymnopoulos, M.; Weber, C.; Stühmer, W.; Pardo, L. A.: Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. Journal of Biological Chemistry 283 (52), S. 36234 - 36240 (2008)

Pardo, L. A.; Stühmer, W.: Eag1: an emerging oncological target. Cancer Research 68 (6), S. 1611 - 1613 (2008)

Fraser, S. P.; Pardo, L. A.: Ion channels: functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer. EMBO Reports 9 (6), S. 512 - 515 (2008)

Herrero-Herranz, E.; Pardo, L. A.; Gold, R.; Linker, R. A.: Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiology of Disease 30, S. 162 - 173 (2008)

Martin, S.; Lino de Oliveira, C.; Mello de Queiroz, F.; Pardo, L. A.; Stühmer, W.; Del Bel, E.: Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain. Neuroscience 155, S. 833 - 844 (2008)

Pardo, L. A.; Stühmer, W.: Eag1 as a cancer target. Expert Opinion on Therapeutic Targets 12 (7), S. 837 - 843 (2008)

Gomez-Varela, D.; Zwick-Wallasch, E.; Knötgen, H.; Sanchez, A.; Hettmann, T.; Ossipov, D.; Weseloh, R.; Contreras-Jurado, C.; Rothe, M.; Stühmer, W. et al.; Pardo, L. A.: Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Research 67 (15), S. 7343 - 7349 (2007)

Herrero-Herranz, E.; Pardo, L. A.; Bunt, G.; Gold, R.; Stühmer, W.; Linker, R. A.: Re-expression of a developmentally restricted potassium channel in autoimmune demyelination - Kv1.4 is implicated in oligodendroglial proliferation. American Journal of Pathology 171 (2), S. 589 - 598 (2007)

Hemmerlein, B.; Weseloh, R. M.; Mello de Queiroz, F.; Knötgen, H.; Sanchez, A.; Rubio, M. E.; Martin, S.; Schliephacke, T.; Jenke, M.; Radzun, H.-J. et al.; Stühmer, W.; Pardo, L. A.: Overexpression of EagI potassium channels in clinical tumours. Molecular Cancer 5, 41 (2006)

Mello de Queiroz, F.; Suarez-Kurtz, G.; Stühmer, W.; Pardo, L. A.: Ether à go-go potassium channel expression in soft tissue sarcoma patients. Molecular Cancer 5, 42 (2006)